Literature DB >> 629874

Treatment of eczema with cyclophosphamide and azathioprine.

J G Morrison, E J Schulz.   

Abstract

Nine patients with eczema were treated with the immunosuppressive drugs cyclophosphamide and azathioprine. In all patients the eczema was severe and incapacitating and had not responded satisfactorily to systemic and topical corticosteroid therapy. The eczema improved in all patients and systemic corticosteroids, which had resulted in undesirable side-effects, could be decreased or stopped. Leukopenia was not necessary for achieving clinical improvement. Several months of treatment were needed to obtain significant improvement in the eczema and long term remissions followed cessation of therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629874     DOI: 10.1111/j.1365-2133.1978.tb01623.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Lymphocyte subsets in patients with compositae oleoresin dermatitis and increased UVA sensitivity during treatment with azathioprine.

Authors:  O Baadsgaard; C Geisler; T Plesner; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 2.  Treatment of atopic dermatitis: old and new modalities.

Authors:  A R Rhodes
Journal:  Clin Rev Allergy       Date:  1986-02

Review 3.  Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics.

Authors:  A Anstey
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.